Khaled Elsayad , Emmanuella Guenova , Chalid Assaf , Jan P. Nicolay , Franz Trautinger , Rudolf Stadler , Cora Waldstein , Tom Boterberg , Paul Meijnders , Youlia Kirova , Gabor Dobos , Victor Duque-Santana , Elena Riggenbach , Wael Elsheshtawy , Anne Niezink , Evangelia Papadavid , Julia Scarisbrick , Maarten Vermeer , Karen J. Neelis , Martine Bagot , Dora Correia
{"title":"皮肤淋巴瘤的放射治疗：EORTC 皮肤淋巴瘤肿瘤小组的建议","authors":"Khaled Elsayad , Emmanuella Guenova , Chalid Assaf , Jan P. Nicolay , Franz Trautinger , Rudolf Stadler , Cora Waldstein , Tom Boterberg , Paul Meijnders , Youlia Kirova , Gabor Dobos , Victor Duque-Santana , Elena Riggenbach , Wael Elsheshtawy , Anne Niezink , Evangelia Papadavid , Julia Scarisbrick , Maarten Vermeer , Karen J. Neelis , Martine Bagot , Dora Correia","doi":"10.1016/j.ejca.2024.115064","DOIUrl":null,"url":null,"abstract":"<div><div>The number of primary cutaneous lymphoma patients receiving low-dose radiotherapy is increasing, though controlled clinical trials defining the standard radiation dose for each specific entity have not yet been completed. Radiation oncologists are left with making highly individualized decisions that would be better enriched by additional clinical evidence. In this expert opinion, we aim to provide a clear recommendation to improve the current practice of radiation oncology. In addition, existing literature has been reviewed to develop recommendations for all types of primary cutaneous lymphoma. A prospective trial is urgently needed to identify the factors influencing patient outcomes following different radiation doses.</div></div>","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group\",\"authors\":\"Khaled Elsayad , Emmanuella Guenova , Chalid Assaf , Jan P. Nicolay , Franz Trautinger , Rudolf Stadler , Cora Waldstein , Tom Boterberg , Paul Meijnders , Youlia Kirova , Gabor Dobos , Victor Duque-Santana , Elena Riggenbach , Wael Elsheshtawy , Anne Niezink , Evangelia Papadavid , Julia Scarisbrick , Maarten Vermeer , Karen J. Neelis , Martine Bagot , Dora Correia\",\"doi\":\"10.1016/j.ejca.2024.115064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The number of primary cutaneous lymphoma patients receiving low-dose radiotherapy is increasing, though controlled clinical trials defining the standard radiation dose for each specific entity have not yet been completed. Radiation oncologists are left with making highly individualized decisions that would be better enriched by additional clinical evidence. In this expert opinion, we aim to provide a clear recommendation to improve the current practice of radiation oncology. In addition, existing literature has been reviewed to develop recommendations for all types of primary cutaneous lymphoma. A prospective trial is urgently needed to identify the factors influencing patient outcomes following different radiation doses.</div></div>\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2024-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S095980492401030X\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S095980492401030X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group
The number of primary cutaneous lymphoma patients receiving low-dose radiotherapy is increasing, though controlled clinical trials defining the standard radiation dose for each specific entity have not yet been completed. Radiation oncologists are left with making highly individualized decisions that would be better enriched by additional clinical evidence. In this expert opinion, we aim to provide a clear recommendation to improve the current practice of radiation oncology. In addition, existing literature has been reviewed to develop recommendations for all types of primary cutaneous lymphoma. A prospective trial is urgently needed to identify the factors influencing patient outcomes following different radiation doses.
期刊介绍：
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
